Reduced hospital stay, morphine consumption, and pain intensity with local infiltration analgesia after unicompartmental knee arthroplasty

Per Essving, Kjell Axelsson, Jill Kjellberg, Orjan Wallgren, Anil Gupta, Anders Lundin, Per Essving, Kjell Axelsson, Jill Kjellberg, Orjan Wallgren, Anil Gupta, Anders Lundin

Abstract

Background and purpose: The degree of postoperative pain is usually moderate to severe following knee arthroplasty. We investigated the efficacy of local administration of analgesics into the operating area, both intraoperatively and postoperatively.

Methods: 40 patients undergoing unicompartmental knee arthroplasty (UKA) were randomized into 2 groups in a double-blind study (ClinicalTrials.gov identifier: NCT00653926). In group A (active), 200 mg ropivacaine, 30 mg ketorolac, and 0.5 mg epinephrine (total volume 106 mL) were infiltrated intraoperatively into the soft tissue, while in group P (placebo), no injections were given. 21 hours postoperatively, 150 mg ropivacain, 30 mg ketorolac, and 0.1 mg epinephrine were injected intraarticularly via a catheter in group A, whereas patients in group P were injected with the same volume of saline (22 mL).

Results: Median hospital stay was shorter in group A than in group P: 1 (1-6) days as opposed to 3 (1-6) days (p < 0.001). Postoperative pain in group A was statistically significantly lower at rest after 6 h and 27 h and on movement after 6, 12, 22, and 27 h. Morphine consumption was statistically significantly lower in group A for the first 48 h, resulting in a lower frequency of nausea, pruritus, and sedation. Postoperatively, there were improved functional scores (Oxford knee score and EQ-5D) in both groups relative to the corresponding preoperative values.

Interpretation: Local injection of analgesics periarticularly at the end of the operation and intraarticularly at 21 h postoperatively provided excellent pain relief and earlier home discharge following UKA. There was a high degree of patient satisfaction in both groups after 6 months (Clinical Trials.gov: NCT 00653926).

Figures

Figure 1.
Figure 1.
Flow chart for the study.
Figure 2.
Figure 2.
Day 1 represents the first postoperative day. Group A (active)= intraoperative, periarticular infiltration: 200 mg ropivacaine, 30mg ketorolac and 0.5 mg epinephrine; postoperative, intraarticular injection: 150 mg ropivacaine, 30 mg ketorolac and 0.1 mg epinephrine. Group P (placebo)= no intraoperative infiltration and postoperative, intraarticular injection: 22 mL saline. The median discharge times are shown: Group A = day 1 and in Group P = day 3 (p

Figure 3.

Postoperative pain at rest. VAS…

Figure 3.

Postoperative pain at rest. VAS scores are presented as median and interquartile range…

Figure 3.
Postoperative pain at rest. VAS scores are presented as median and interquartile range (IQR). * p = 0.003 (6 h); p = 0.004 (27 h).

Figure 4.

Postoperative pain on movement. VAS…

Figure 4.

Postoperative pain on movement. VAS scores are presented as median and interquartile range…

Figure 4.
Postoperative pain on movement. VAS scores are presented as median and interquartile range (IQR). * p
Similar articles
Cited by
References
    1. Axelsson K, Johanzon E, Essving P, Weckstrom J, Ekback G. Postoperative extradural analgesia with morphine and ropivacaine. A double–blind comparison between placebo and ropivacaine 10 mg/h or 16 mg/h. Acta Anaesthesiol Scand. 2005;49:1191–9. - PubMed
    1. Beard DJ, Murray DW, Rees JL, Price AJ, Dodd CA. Accelerated recovery for unicompartmental knee replacement––a feasibility study. Knee. 2002;9:221–4. - PubMed
    1. Berend KR, Lombardi AVJR. Liberal indications for minimally invasive oxford unicondylar arthroplasty provide rapid functional recovery and pain relief. Surg Technol Int. 2007;16:193–7. - PubMed
    1. Carlsson LV, Albrektsson BE, Regner LR. Minimally invasive surgery vs conventional exposure using the Miller–Galante unicompartmental knee arthroplasty: a randomized radiostereometric study. J Arthroplasty. 2006;21:151–6. - PubMed
    1. Fransen M, Edmonds J. Gait variables: appropriate objective outcome measures in rheumatoid arthritis. Rheumatology (Oxford) 1999;38:663–7. - PubMed
Show all 17 references
Publication types
MeSH terms
Associated data
Full text links [x]
[x]
Cite
Copy Download .nbib
Format: AMA APA MLA NLM
Figure 3.
Figure 3.
Postoperative pain at rest. VAS scores are presented as median and interquartile range (IQR). * p = 0.003 (6 h); p = 0.004 (27 h).
Figure 4.
Figure 4.
Postoperative pain on movement. VAS scores are presented as median and interquartile range (IQR). * p

References

    1. Axelsson K, Johanzon E, Essving P, Weckstrom J, Ekback G. Postoperative extradural analgesia with morphine and ropivacaine. A double–blind comparison between placebo and ropivacaine 10 mg/h or 16 mg/h. Acta Anaesthesiol Scand. 2005;49:1191–9.
    1. Beard DJ, Murray DW, Rees JL, Price AJ, Dodd CA. Accelerated recovery for unicompartmental knee replacement––a feasibility study. Knee. 2002;9:221–4.
    1. Berend KR, Lombardi AVJR. Liberal indications for minimally invasive oxford unicondylar arthroplasty provide rapid functional recovery and pain relief. Surg Technol Int. 2007;16:193–7.
    1. Carlsson LV, Albrektsson BE, Regner LR. Minimally invasive surgery vs conventional exposure using the Miller–Galante unicompartmental knee arthroplasty: a randomized radiostereometric study. J Arthroplasty. 2006;21:151–6.
    1. Fransen M, Edmonds J. Gait variables: appropriate objective outcome measures in rheumatoid arthritis. Rheumatology (Oxford) 1999;38:663–7.
    1. Gupta A, Axelsson K, Allvin R, Liszka–hackzell J, Rawal N, Althoff B, Augustini BG. Postoperative pain following knee arthroscopy: the effects of intra–articular ketorolac and/or morphine. Reg Anesth Pain Med. 1999;24:225–30.
    1. Jahromi I, Walton NP, Dobson PJ, Lewis PL, Campbell DG. Patient–perceived outcome measures following unicompartmental knee arthroplasty with mini–incision. Int Orthop. 2004;28:286–9.
    1. Kerr DR, Kohan L. Local infiltration analgesia: a technique for the control of acute postoperative pain following knee and hip surgery: a case study of 325 patients. Acta Orthop. 2008;79:174–83.
    1. Lombardi AV, Jr, Berend KR, Mallory TH, Dodds KL, Adams JB. Soft tissue and intra–articular injection of bupivacaine, epinephrine, and morphine has a beneficial effect after total knee arthroplasty. Clin Orthop. 2004;(428):125–30.
    1. Mcnamee DA, Parks L, Milligan KR. Post–operative analgesia following total knee replacement: an evaluation of the addition of an obturator nerve block to combined femoral and sciatic nerve block. Acta Anaesthesiol Scand. 2002;46:95–9.
    1. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuroaxial blockade in Sweden. Anesthesiology. 2004;100:950–9.
    1. Niemi G, Breivik H. Epinephrine markedly improves thoracic epidural analgesia produced by a small–dose infusion of ropivacaine, fentanyl, and epinephrine after major thoracic or abdominal surgery: a randomized, double–blinded crossover study with and without epinephrine. Anesth Analg. 2002;94:1598–605. table of contents.
    1. Reilly KA, Beard DJ, Barker KL, Dodd CA, Price AJ, Murray DW. Efficacy of an accelerated recovery protocol for Oxford unicompartmental knee arthroplasty––a randomised controlled trial. Knee. 2005;12:351–7.
    1. Reuben SS, Connelly NR. Postoperative analgesia for outpatient arthroscopic knee surgery with intraarticular bupivacaine and ketorolac. Anesth Analg. 1995;80:1154–7.
    1. Röstlund T, Kehlet H. High–dose local infiltration analgesia after hip and knee replacement–what is it, why does it work, and what are the future challenges? Acta Orthop. 2007;78:159–61.
    1. Toftdahl K, Nikolajsen L, Haraldsted V, Madsen F, Tonnesen EK, Soballe K. Comparison of peri– and intraarticular analgesia with femoral nerve block after total knee arthroplasty: a randomized clinical trial. Acta Orthop. 2007;78:172–9.
    1. Wang H, Boctor B, Verner J. The effect of single–injection femoral nerve block on rehabilitation and length of hospital stay after total knee replacement. Reg Anesth Pain Med. 2002;27:139–44.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe